2010 Fiscal Year Final Research Report
Search on molecular target cancer drug from microbial secondary metabolites
Project/Area Number |
20590107
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Drug development chemistry
|
Research Institution | Iwaki Meisei University |
Principal Investigator |
KIM Yongpil Iwaki Meisei University, 薬学部・薬学科, 准教授 (70337997)
|
Co-Investigator(Kenkyū-buntansha) |
HAYASHI Masahiko いわき明星大学, 薬学部・薬学科, 教授 (20164965)
|
Project Period (FY) |
2008 – 2010
|
Keywords | 分子標的治療薬 / 微生物二次代謝産物 / HIF-1α / 低酸素 |
Research Abstract |
It aimed at the treatment with high selective effect for cancer, HIF-1α (hypoxic inducible factor-1α) was made a molecular target from microbial secondary metabolites, we obtained a new type lead compounds. We expect that these compounds become a new type anti-cancer drug if anti-cancer mechanism action is clarified in the future.
|
-
-
-
[Journal Article] Cyslabdan, a New Potentiator of Imipenem Activity against Methicillin-resistant Staphylococcus aureus, Produced by Streptomyces sp. K04-0144 I. Taxonomy, Fermentation, Isolation and Structural Elucidation2009
Author(s)
A. Fukumoto, Y.P. Kim,, A. Matsumoto, Y. Takahashi, K. Shiomi, H. Tomoda S. Omura
-
Journal Title
Peer Reviewed
-
-
-
-